575.0K XNAS Volume
XNAS 24 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Maria Palasis | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 183,333 | 183,333 | - | - | Employee Stock Option (right to buy) | |
| Harlan W. Waksal | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 128,333 | 0 | - | - | Performance-based Restricted Stock Units | |
| Jason Cavalier | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Oct 2024 | 100,000 | 100,000 | - | 0 | Common Stock | |
| Maria Palasis | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Oct 2024 | 300,000 | 300,000 | - | 0 | Common Stock | |
| C. Ann Merrifield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 30,000 | 30,000 | - | - | Stock Option | |
| James R. Tobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 30,000 | 30,000 | - | - | Stock Option | |
| W. Bradford Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 30,000 | 30,000 | - | - | Stock Option | |
| Nancy L. Snyderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 30,000 | 30,000 | - | - | Stock Option | |
| Konstantin Poukalov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 30,000 | 30,000 | - | - | Stock Option | |
| Michael Altman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 30,000 | 30,000 | - | - | Stock Option | |
| Maria Palasis | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 500,000 | 500,000 | - | - | Stock Option | |
| Harlan W. Waksal | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 275,000 | 536,966 | - | 0 | Common Stock | |
| Bishop E. John | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2024 | 200,000 | 200,000 | - | - | Stock Options | |
| Jason Cavalier | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2024 | 200,000 | 200,000 | - | - | Stock Options | |
| Nieman Richard | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2024 | 200,000 | 200,000 | - | - | Stock Options | |
| C. Ann Merrifield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option | |
| James R. Tobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option | |
| W. Bradford Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option | |
| Nancy L. Snyderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option | |
| Konstantin Poukalov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option | |
| Michael Altman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option | |
| Maria Palasis | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 150,000 | 150,000 | - | - | Stock Option | |
| John E. Bishop | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 220,000 | 220,000 | - | - | Stock Option | |
| Maria Palasis | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 250,000 | 250,000 | - | - | Stock Option | |
| Richard Nieman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 55,537 | 55,537 | - | - | Stock Option | |
| Jason Cavalier | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 140,000 | 140,000 | - | - | Stock Option | |
| Robert E. Richard | SVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 30,000 | 30,000 | - | 0 | Common Stock | |
| Robert E. Richard | SVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 45,000 | 45,000 | - | - | Stock Option | |
| Corinne Noyes | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 36,667 | 36,667 | - | 0 | Common Stock | |
| Harlan W. Waksal | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 200,000 | 200,000 | - | - | Stock Option | |
| Corinne Noyes | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 55,000 | 55,000 | - | - | Stock Option | |
| Richard Nieman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 230,000 | 230,000 | - | - | Stock Option | |
| C. Ann Merrifield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 7,250 | 7,250 | - | - | Stock Option | |
| Harlan W. Waksal | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 953,002 | 953,002 | - | - | Stock Option | |
| W. Bradford Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 7,250 | 7,250 | - | - | Stock Option | |
| Nancy L. Snyderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 7,250 | 7,250 | - | - | Stock Option | |
| Konstantin Poukalov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 7,250 | 7,250 | - | - | Stock Option | |
| Michael Altman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 7,250 | 7,250 | - | - | Stock Option | |
| C. Ann Merrifield | Director | Purchase of securities on an exchange or from another person at price $ 5.05 per share. | 10 Jun 2022 | 4,000 | 11,328 | - | 5.1 | 20,200 | Common Stock |
| C. Ann Merrifield | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 13 May 2022 | 328 | 7,328 | - | 5 | 1,640 | Common Stock |
| C. Ann Merrifield | Director | Purchase of securities on an exchange or from another person at price $ 4.81 per share. | 13 May 2022 | 3,500 | 7,000 | - | 4.8 | 16,846 | Common Stock |
| Harlan W. Waksal | Director, Executive Chair | Purchase of securities on an exchange or from another person at price $ 4.22 per share. | 12 Apr 2022 | 236,966 | 236,966 | - | 4.2 | 999,997 | Common Stock |
| James R. Tobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 14,500 | 14,500 | - | - | Stock Option | |
| Harlan W. Waksal | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 520,000 | 520,000 | - | - | Stock Option | |
| Maria Palasis | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 175,000 | 175,000 | - | - | Stock Option | |
| Maria Palasis | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2022 | 127,400 | 127,400 | - | - | Stock Option | |
| Corinne Noyes | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2022 | 32,000 | 32,000 | - | - | Stock Option | |
| Robert E. Richard | SVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2022 | 35,000 | 35,000 | - | - | Stock Option | |
| Pamela E. Nelson | SVP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2022 | 30,000 | 30,000 | - | - | Stock Option | |
| Jason Cavalier | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2022 | 15,605 | 15,605 | - | - | Stock Option | |
| Jason Cavalier | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2021 | 104,000 | 104,000 | - | - | Stock Options (Right to Buy) | |
| C. Ann Merrifield | Director | Purchase of securities on an exchange or from another person at price $ 8.97 per share. | 17 Jun 2021 | 3,500 | 3,500 | - | 9.0 | 31,395 | Common Stock |
| C. Ann Merrifield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 7,250 | 7,250 | - | - | Stock Option | |
| W. Bradford Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 7,250 | 7,250 | - | - | Stock Option | |
| Nancy L. Snyderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 7,250 | 7,250 | - | - | Stock Option | |
| Konstantin Poukalov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 7,250 | 7,250 | - | - | Stock Option | |
| Michael Altman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 7,250 | 7,250 | - | - | Stock Option | |
| R. Donald Elsey | CFO, Treasurer & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 45,000 | 45,000 | - | - | Stock Option | |
| Maria Palasis | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 120,000 | 120,000 | - | - | Stock Option | |
| Corinne Noyes | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 30,000 | 30,000 | - | - | Stock Option | |
| Robert E. Richard | SVP of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 18,000 | 18,000 | - | - | Stock Option | |
| Pamela E. Nelson | Senior VP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 13,000 | 13,000 | - | - | Stock Option | |
| Nancy L. Snyderman | Director | Purchase of securities on an exchange or from another person at price $ 9.72 per share. | 16 Dec 2020 | 1,025 | 1,025 | - | 9.7 | 9,963 | Common Stock |
| Nancy L. Snyderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2020 | 14,500 | 14,500 | - | - | Stock Option | |
| Pamela E. Nelson | Senior VP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 35,000 | 35,000 | - | - | Stock Option | |
| Robert . E. Richard | SVP of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2020 | 35,000 | 35,000 | - | - | Stock Option | |
| George M. Whitesides | Director | 05 May 2020 | 97,216 | 0 | - | - | Series A-1/A Convertible Preferred Stock | ||
| George M. Whitesides | Director | 05 May 2020 | 67,672 | 0 | - | - | Series A-1/C Convertible Preferred Stock | ||
| George M. Whitesides | Director | 05 May 2020 | 55,991 | 0 | - | - | Series A-1/B Convertible Preferred Stock | ||
| George M. Whitesides | Director | 05 May 2020 | 6,404 | 55,064 | - | 0 | Common Stock | ||
| Robert S. Langer | Director | 05 May 2020 | 668 | 15,167 | - | - | Common Stock | ||
| Robert S. Langer | Director | 05 May 2020 | 23,057 | 0 | - | - | Series A-1/A Convertible Preferred Stock | ||
| Corinne Noyes | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 9,782 | 9,782 | - | - | Stock Option | |
| Laura Edgerly-Pflug | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 20,046 | 20,046 | - | - | Stock Option | |
| George M. Whitesides | Director | Grant, award, or other acquisition of securities at price $ 16.00 per share. | 30 Apr 2020 | 19,661 | 48,660 | - | 16 | 314,576 | Common Stock |
| George M. Whitesides | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 14,500 | 14,500 | - | - | Stock Option | |
| R. Donald Elsey | CFO, Treasurer & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 20,635 | 20,635 | - | - | Stock Option | |
| Robert S. Langer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 14,500 | 14,500 | - | - | Stock Option | |
| Konstantin Poukalov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 14,500 | 14,500 | - | - | Stock Option | |
| Michael Altman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 14,500 | 14,500 | - | - | Stock Option | |
| Maria Palasis | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 326,303 | 326,303 | - | - | Stock Option |